An Open Trial of Allopurinol in Patients With Poorly Responsive Schizophrenia

• Status: Completed
• Trial end date: 2008-08-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a four week open label trial of ALLOPURINOL to the treatment regime of ten (10) poorly responsive patients with schizophrenia, monitoring their response and side-effects. No change in medication is required.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bronx Psychiatric Center
• Treatments: Allopurinol

Criteria

Inclusion Criteria:

• Subjects with schizophrenia and poor response (no prospect of discharge because of symptoms)

Exclusion Criteria:

• Over 65

• Renal or liver disease

• Diabetes

• Hypertension

• Taking thiazides or ACE inhibitors